Literature DB >> 28106307

Normal saline is associated with increased sickle red cell stiffness and prolonged transit times in a microfluidic model of the capillary system.

Marcus A Carden1,2, Meredith Fay1,2,3,4, Yumiko Sakurai1,2,3,4, Brynn McFarland5, Sydney Blanche2, Caleb DiPrete2, Clinton H Joiner1, Todd Sulchek3,6, Wilbur A Lam1,2,3,4.   

Abstract

OBJECTIVE: Vaso-occlusive crisis (VOC) is a complex process that occurs in patients with sickle cell disease (SCD) and is often associated with pain and urgent hospitalization. A major instigator of VOC is microvascular obstruction by pathologically stiffened sickle red blood cells (RBCs), and thus, therapy relies heavily on optimizing intravenous fluid (IVF) hydration to increase RBC deformability. However, no evidence-based guidelines regarding the choice of IVF currently exist. We therefore analyzed alterations in biomechanical properties of sickle RBCs isolated from patients with homozygous SCD (hemoglobin SS) after exposure to different osmolarities of clinical IVF formulations.
METHODS: Atomic force microscopy (AFM) was used to assess stiffness of RBCs after exposure to different IVFs. A microfluidic model of the human capillary system was used to assess transit time (TT) and propensity to occlusion after exposure to the different IVF formulations.
RESULTS: Sickle RBCs exposed to normal saline (NS) had increased stiffness, TTs, and propensity to microchannel occlusion compared to other osmolarities.
CONCLUSION: NS, an IVF formulation often used to treat patients with SCD during VOC, may induce localized microvascular obstruction due to alterations of sickle RBC biomechanical properties.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  atomic force microscopy; cellular mechanics; intravenous fluids; microfluidics; sickle-cell disease; vaso-occlusion

Mesh:

Substances:

Year:  2017        PMID: 28106307     DOI: 10.1111/micc.12353

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  8 in total

1.  Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells.

Authors:  Pradeep Kumar; Tekla Smith; Reben Raeman; Daniel M Chopyk; Hannah Brink; Yunshan Liu; Todd Sulchek; Frank A Anania
Journal:  J Biol Chem       Date:  2018-06-25       Impact factor: 5.157

2.  Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.

Authors:  Marcus A Carden; David C Brousseau; Fahd A Ahmad; Jonathan Bennett; Seema Bhatt; Amanda Bogie; Kathleen Brown; Theron Charles Casper; Laura L Chapman; Corrie E Chumpitazi; Daniel Cohen; Carlton Dampier; Angela M Ellison; Hartmut Grasemann; Robert W Hickey; Lewis L Hsu; Sara Leibovich; Elizabeth Powell; Rachel Richards; Syana Sarnaik; Debra L Weiner; Claudia R Morris
Journal:  Am J Hematol       Date:  2019-04-29       Impact factor: 10.047

Review 3.  Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease.

Authors:  Melissa Azul; Eudorah F Vital; Wilbur A Lam; David K Wood; Joan D Beckman
Journal:  Transl Res       Date:  2022-03-27       Impact factor: 10.171

Review 4.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

5.  Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.

Authors:  Marcus A Carden; Meredith E Fay; Xinran Lu; Robert G Mannino; Yumiko Sakurai; Jordan C Ciciliano; Caroline E Hansen; Satheesh Chonat; Clinton H Joiner; David K Wood; Wilbur A Lam
Journal:  Blood       Date:  2017-10-04       Impact factor: 25.476

Review 6.  Perioperative Management of Sickle Cell Disease.

Authors:  Kwame Ofori Adjepong; Folashade Otegbeye; Yaw Amoateng Adjepong
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

7.  How I Treat Acute and Persistent Sickle Cell Pain.

Authors:  Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

8.  Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.

Authors:  Aafke E Gaartman; Ajab K Sayedi; Jorn J Gerritsma; Tim R de Back; Charlotte F van Tuijn; Man Wai Tang; Harriët Heijboer; Koen de Heer; Bart J Biemond; Erfan Nur
Journal:  Br J Haematol       Date:  2021-07-15       Impact factor: 6.998

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.